Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2006 by Weintraub, Michael I., MD, FACP, FAAN.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Nu-Magnetics Inc.
Information provided by:
Weintraub, Michael I., MD, FACP, FAAN
ClinicalTrials.gov Identifier:
NCT00123136
First received: July 20, 2005
Last updated: June 28, 2006
Last verified: June 2006

July 20, 2005
June 28, 2006
August 2005
Not Provided
  • reduction of neuropathic foot pain
  • improve quality of life
reduction of neuropathic foot pain, improve quality of life
Complete list of historical versions of study NCT00123136 on ClinicalTrials.gov Archive Site
serial changes in EDX, QST, autonomic functions, biopsy
Same as current
Not Provided
Not Provided
 
Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy
Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy. Multi-Center, Randomized Placebo Controlled Trial

The researchers will study the application of a commercial pulsed magnetic stimulating device to the feet of patients with moderate-severe foot pain secondary to diabetic peripheral neuropathy (DPN).

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Diabetic Neuropathies
Device: foot energizer
Not Provided
Weintraub MI, Herrmann DN, Smith AG, Backonja MM, Cole SP. Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial. Arch Phys Med Rehabil. 2009 Jul;90(7):1102-9.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
250
December 2006
Not Provided

Inclusion Criteria:

  • DPN stage 2 and 3; symptomatic > 6 months

Exclusion Criteria:

  • Pacemaker in patient or mate
Both
18 Years to 90 Years
No
Contact: Michael I. Weintraub, MD 914-941-0788 miwneuro@pol.net
United States
 
NCT00123136
2005-81440-DPN
Not Provided
Not Provided
Weintraub, Michael I., MD, FACP, FAAN
Nu-Magnetics Inc.
Principal Investigator: Michael Weintraub, MD New York Medical College
Weintraub, Michael I., MD, FACP, FAAN
June 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP